Objective:

To evaluate the association between glycemic variability (GV) and short-term all-cause mortality in adult patients hospitalized with COVID-19.

Approach:

Key Findings:

• Include the number of studies and patients.

Interpretation:

Higher GV is associated with increased short-term mortality in hospitalized patients with COVID-19, suggesting its potential as a prognostic marker.

Limitations:

• Specify examples of confounding factors.

Conclusion:

Emphasize implications for clinical practice.

Sources:

• Source
Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.